Infectious Disease

Top Story

Two dengue drugs enter phase 2 trials

August 30, 2015

Singapore’s National Medical Research Council has awarded a grant to Singapore General Hospital supporting entry of two dengue treatments — the antiviral celgosivir and the disease-modifying modipafant — into phase 2 clinical trials next March, according to a press release.

Celgosivir is an alpha glucosidase inhibitor, while modipafant is a platelet-activating factor receptor antagonist. 60 Degrees Pharmaceuticals and researchers at the hospital will evaluate the safety and efficacy of the two drugs in dengue fever patients.

CDC unveils interactive tool to track antibiotic resistance over time

August 29, 2015
The CDC has launched a new interactive tool that allows anyone to observe changes in antibiotic resistance across four types of foodborne pathogens in the United States…
photo of gregory phillips In the Journals

HIV testing rates low for gay male adolescents

August 28, 2015
Gay and bisexual teenage boys were unlikely to undergo HIV testing, according to research published in the Journal of Adolescent Health. “As one of the first…
One in four patients with HCV denied initial request for treatment In the Journals

One in four patients with HCV denied initial request for treatment

August 28, 2015
A new study published in PLoS ONE showed that one in four patients with hepatitis C virus infection who apply for treatment of the infection is initially…
Carrie Byington In the Journals

Presence of children in household increases likelihood of viral detection

August 28, 2015
Children living in households put each family member at greater risk for viral infection, according to results from the Utah Better Identification of Germs-Longitudinal…
More News Headlines »
Infectious Disease Case Consults

The Patient with Acute-Bacterial Skin and Skin-Structure Infections

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with acute-bacterial skin and skin-structure…
More »
At Issue Video
VIDEO: Cure is ‘next frontier’ of HIV

VIDEO: Cure is ‘next frontier’ of HIV

July 1, 2015
Timothy Brown – the Berlin patient – has led researchers to the next frontier of HIV research, according to…
More »

HCV VOICE II: Optimizing Virological Outcomes with Integrated HCV Education

This activity is supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »